2/27/24 19:58 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 783 | D | | | | | | | | | | | | | | |
2/27/24 19:56 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 10 | 99 | D | | | | | | | | | | | | | | |
2/27/24 19:54 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 7 | 102 | D | | | | | | | | | | | | | | |
2/27/24 19:54 | 2/27/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.7322 | 0 | -3 | -3 | 102 | D | | | | | | | | | | | | | | |
12/4/23 16:54 | 11/30/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rothera Mark | CA | DO | P,CEO | P.m | 49 | 0.4936 | 0 | 100 | New | 100 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 7 | 99 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/28/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.5000 | 0 | -4 | -4 | 99 | D | | | | | | | | | | | | | | |
11/28/23 19:03 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 757 | D | | | | | | | | | | | | | | |
11/28/23 19:01 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 11 | 90 | D | | | | | | | | | | | | | | |
8/29/23 18:52 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 732 | D | | | | | | | | | | | | | | |
8/29/23 18:49 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 12 | 81 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 96 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/28/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.45 | 0 | -4 | -4 | 96 | D | | | | | | | | | | | | | | |
5/26/23 19:32 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 707 | D | | | | | | | | | | | | | | |
5/26/23 19:30 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 92 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.42 | 0 | -4 | -4 | 92 | D | | | | | | | | | | | | | | |
2/28/23 18:30 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 682 | D | | | | | | | | | | | | | | |
2/28/23 18:28 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 9 | 48 | D | | | | | | | | | | | | | | |
2/28/23 18:28 | 2/27/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.68 | 0 | -2 | -4 | 48 | D | | | | | | | | | | | | | | |
2/28/23 18:25 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 17 | 63 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 89 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/27/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -6 | 1.68 | 0 | -4 | -4 | 89 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 9 | 86 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -10 | 2.72 | 0 | -4 | -4 | 86 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 46 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -6 | 2.72 | 0 | -2 | -4 | 46 | D | | | | | | | | | | | | | | |
11/29/22 17:21 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 20 | 54 | D | | | | | | | | | | | | | | |
11/29/22 17:18 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 657 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 44 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -9 | 4.01 | 0 | -2 | -5 | 44 | D | | | | | | | | | | | | | | |
8/29/22 21:16 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 25 | 45 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 9 | 82 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -15 | 4.02 | 0 | -4 | -4 | 82 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 631 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -54 | 4.01 | 0 | -13 | -2 | 631 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 620 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -25 | 1.90 | 0 | -13 | -2 | 620 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 42 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.90 | 0 | -2 | -5 | 42 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 10 | 79 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -7 | 1.90 | 0 | -4 | -4 | 79 | D | | | | | | | | | | | | | | |
3/1/22 21:13 | 2/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 607 | D | | | | | | | | | | | | | | |
3/1/22 21:13 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -41 | 2.78 | 0 | -15 | -2 | 607 | D | | | | | | | | | | | | | | |
3/1/22 21:12 | 2/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 40 | D | | | | | | | | | | | | | | |
3/1/22 21:12 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -7 | 2.78 | 0 | -2 | -6 | 40 | D | | | | | | | | | | | | | | |
3/1/22 21:11 | 2/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 50 | 27 | D | | | | | | | | | | | | | | |
3/1/22 21:10 | 2/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 10 | 76 | D | | | | | | | | | | | | | | |
3/1/22 21:10 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -11 | 2.78 | 0 | -4 | -5 | 76 | D | | | | | | | | | | | | | | |
12/30/21 18:47 | 12/29/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 6 | 0.9000 | 0 | 7 | 1 | 597 | D | | | | | | | | | | | | | | |
11/29/21 19:51 | 11/25/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 18 | New | 18 | D | | | | | | | | | | | | | | |
11/29/21 19:50 | 11/25/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 8 | 27 | 38 | D | | | | | | | | | | | | | | |
11/29/21 19:50 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.dm | -22 | 4.81 | 0 | -5 | -11 | 38 | D | | | | | | | | | | | | | | |
11/29/21 19:48 | 11/25/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 14 | 23 | 73 | D | | | | | | | | | | | | | | |
11/29/21 19:48 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.dm | -36 | 4.81 | 0 | -8 | -9 | 73 | D | | | | | | | | | | | | | | |
11/29/21 19:46 | 11/25/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 50 | 9 | 590 | D | | | | | | | | | | | | | | |
11/29/21 19:46 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.dm | -133 | 4.81 | 0 | -28 | -4 | 590 | D | | | | | | | | | | | | | | |
11/15/21 17:59 | 11/15/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | P | 44 | 5.56 | 0 | 8 | 1 | 567 | D | | | | | | | | | | | | | | |
9/29/21 18:04 | 9/28/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 9 | 0.9000 | 0 | 10 | 18 | 67 | D | | | | | | | | | | | | | | |